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Eo the Editor: Post-exercise release of cardiac troponin (cTn)T and
TnI has been previously reported after prolonged bouts of exercise
1). However, this release has only been observed in a limited
umber of subjects (2). It is unclear whether post-exercise release
f cTn represents necrosis of cardiac myocytes, and thus irrevers-
ble damage, or a transient and reversible change in membrane
ermeability of the myocyte (2). Similarly, whether the substrate
or post-exercise release of cTn is physiologic or pathologic has not
een determined.
We examined the kinetics of cTnT release during and after
ompletion of a marathon using repeated blood draws to investi-
ate the time course of exercise-related elevations in cTnT and to
ifferentiate post-exercise kinetics of cTnT from cTnT release
ubsequent to acute coronary syndrome (ACS). Nine well-trained
en completed a marathon (42.2 km) on a motorized treadmill.
enous blood samples (5 ml) were drawn through a cannula at rest
nd at 30-min intervals during, immediately after, and at 1, 3, 6,
2, and 24 h after exercise. Serum was analyzed for cTnT using the
hird-generation immunoassay (Roche Diagnostics, Lewes, United
ingdom). During the marathon, between 60 and 120 min, cTnT
ncreased in all participants. At race completion, or within 1 h of
ompleting the marathon, cTnT had returned to baseline values in
ll subjects. All but 1 subject showed a further release of cTnT
ithin the 24-h recovery period, with 5 of these subjects having an
levated cTnT 24 h after exercise (Fig. 1). Importantly, these data
re the first to demonstrate that cTnT is released in all persons in
esponse to exercise. Previous studies have reported between 0%
nd 78% of participants having a cTnT positive blood sample after
outs of prolonged exercise (1,3). The time course and biphasic
elease of cTnT shown presently suggest that the discrepancy
etween previous findings may be related to the timing of blood
ampling and the simple pre–post-exercise design that most
uthors have adopted (1,3). The release of cTnT within the first 60
in of exercise indicates that exercise-induced cTnT release is not
ecessarily limited to prolonged endurance exercise. We suggest
hat the consistent elevation and pattern of cTnT observed in all
articipants during and after exercise likely reflect a physiologic as
pposed to pathologic substrate.
Recently, using a highly sensitive assay for cTnI capable of
dentifying single troponin molecules, Wu et al. (4) have shown
hat there is a very low (7 ng/l) background level of cTnI in the
ealthy population. It is possible, therefore, that there is a
ontinual turnover of cTn in the healthy heart and that exercise,
nd the associated increased myocardial demand, is a stimulus for
n increased turnover. It has been previously demonstrated that no
elationship exists between post-exercise cTn release and magnetic
esonance imaging evidence of cardiac damage (5). Further, the
erum concentrations of cTnT observed in our study were rela-
ively small in comparison with those observed after a myocardialnfarction (6). Together, this provides further support of a physi-
logic substrate responsible for post-exercise cTn release. Within
keletal muscle, physiologic adaptation is preceded by protein
reakdown; perhaps exercise-induced cardiac hypertrophy follows
similar model.
Despite the early release and low absolute values, the biphasic
elease of cTnT observed during and after marathon running and
he persistent elevation at 24 h in some subjects mean that 24-h
equenced blood draws cannot be used to differentiate exercise-
nduced cTnT release from the early onset of ACS. Accordingly,
sing cTnT diagnostically for patients admitted with suspected
CS subsequent to bouts of endurance exercise is problematic;
hese patients, therefore, require further work-up.
Early immunoassays for cTn exhibited cross-reactivity with
keletal muscle damage. However, the cardiospecificity of the
hird-generation cTnT assay has been validated in the presence of
ignificant skeletal muscle damage (7). Accordingly, it is unlikely
hat the results of the present study are due to interference from
keletal muscle damage. To further understand exercise-induced
Tn release, future work should use the newly available, highly
ensitive troponin assays.
Until now, release of cTnT has been proposed as pathogno-
onic of cardiac necrosis (8). The present data should prompt
econsideration of this belief. It appears unlikely that minor
levations in cTnT subsequent to endurance exercise are due to
yocardial necrosis. Rather, it is possible that post-exercise cTn
elease represents reversible cardiomyocyte membrane damage that
ay reflect part of a remodeling process. Although cTnT is
iagnostic of ACS in the clinical setting, in a healthy exercising
opulation, cTnT is routinely released in all persons after periods
f increased myocardial demand.
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